Sequoia Financial Advisors LLC Buys 583 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Sequoia Financial Advisors LLC increased its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 2.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,246 shares of the company’s stock after purchasing an additional 583 shares during the period. Sequoia Financial Advisors LLC’s holdings in Privia Health Group were worth $478,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of PRVA. Canada Pension Plan Investment Board acquired a new stake in shares of Privia Health Group during the 2nd quarter worth approximately $26,000. Nisa Investment Advisors LLC grew its holdings in Privia Health Group by 107.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock worth $31,000 after acquiring an additional 930 shares during the period. GAMMA Investing LLC grew its holdings in Privia Health Group by 98.7% during the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after acquiring an additional 845 shares during the period. Signaturefd LLC raised its position in shares of Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after acquiring an additional 626 shares during the last quarter. Finally, Park Place Capital Corp lifted its stake in shares of Privia Health Group by 115.4% in the 1st quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock valued at $49,000 after purchasing an additional 1,335 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Stock Performance

PRVA opened at $17.65 on Monday. The stock has a fifty day moving average of $18.58 and a 200-day moving average of $18.26. The company has a market capitalization of $2.11 billion, a P/E ratio of 117.67, a P/E/G ratio of 4.00 and a beta of 0.76. Privia Health Group, Inc. has a fifty-two week low of $15.92 and a fifty-two week high of $24.35.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.05 by ($0.02). The business had revenue of $422.30 million for the quarter, compared to the consensus estimate of $411.50 million. Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The firm’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.06 earnings per share. On average, equities research analysts predict that Privia Health Group, Inc. will post 0.17 earnings per share for the current fiscal year.

Insider Activity

In other Privia Health Group news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the sale, the chief executive officer now owns 247,771 shares of the company’s stock, valued at approximately $4,583,763.50. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 14.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on PRVA. Robert W. Baird boosted their price objective on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 26th. Evercore ISI cut their target price on Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th. KeyCorp assumed coverage on shares of Privia Health Group in a research note on Friday, October 11th. They set an “overweight” rating and a $23.00 price target for the company. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $28.00 price target on shares of Privia Health Group in a research report on Wednesday, August 14th. Two research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Privia Health Group currently has a consensus rating of “Buy” and an average price target of $24.73.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.